Axogen, Inc.

Axogen, Inc. is a medical device company focused on the development and commercialization of technologies for peripheral nerve regeneration and repair. Its main products include Avance Nerve Graft, a processed nerve allograft for surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid for aligning severed nerve ends; Axoguard Nerve Protector and Axoguard HA+ Nerve Protector, used to protect and wrap damaged nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; and Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft. The company also offers the Avance Method, a technique for processing donated human peripheral nerve tissue. These products are used by plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and oral and maxillofacial surgeons.

Axogen, Inc. is listed on the Nasdaq Capital Market (NasdaqCM) under the ticker symbol AXGN. The company trades in U.S. dollars (USD), as it is headquartered in the United States. The NasdaqCM is a U.S.-based stock exchange that lists smaller-cap companies, and Axogen's listing there provides liquidity and visibility to investors. The currency used for all trading and financial reporting is the U.S. dollar.

Axogen, Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical device company, it focuses on developing and commercializing products for peripheral nerve regeneration and repair. This industry involves the design, manufacture, and sale of devices used in surgical procedures, and Axogen's products are primarily used in nerve repair surgeries. The company's work falls under the broader healthcare umbrella, which includes companies that provide medical technologies, equipment, and services to improve patient outcomes.

Axogen, Inc. is headquartered in Alachua, Florida, United States. The company serves global markets, including hospitals, surgery centers, and military hospitals. It distributes its products through independent in-country distributors, reaching surgeons such as plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons. While the company is based in the U.S., its distribution network allows it to provide peripheral nerve repair technologies to patients and healthcare providers internationally.

Axogen, Inc. generates revenue by selling its portfolio of peripheral nerve repair products to hospitals, surgery centers, and military hospitals. The company's products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Additionally, Axogen offers peripheral nerve tissue recovery and acquisition services, testing, donor medical review and release, debridement and processing steps, packaging, and sterilization. The company markets its products directly to surgeons and through independent in-country distributors, targeting plastic reconstructive, orthopedic hand, and oral and maxillofacial surgeons. This model allows Axogen to monetize its proprietary technologies and processing techniques.